Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
ACXP holding history
Acurx Pharmaceuticals, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACXP overviewAll 13F holders of ACXPFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,500
- Value
- $11.6K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,500 | $11.6K | <0.1% | +1,000+15.4% | Added | Holders |
| Q1 2026 | 6,500 | $24.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 6,500 | $16.2K | <0.1% | +1,190+22.4% | Added | Holders |
| Q3 2025 | 5,310 | $22.8K | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q2 2025 | 106,201 | $54.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 106,201 | $41.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 106,201 | $86.4K | <0.1% | +60,000+129.9% | Added | Holders |
| Q3 2024 | 46,201 | $87.8K | <0.1% | −200−0.4% | Reduced | Holders |
| Q2 2024 | 46,401 | $104.4K | <0.1% | +20,000+75.8% | Added | Holders |
| Q1 2024 | 26,401 | $64.7K | <0.1% | +10,200+63.0% | Added | Holders |
| Q4 2023 | 16,201 | $62.0K | <0.1% | +1,201+8.0% | Added | Holders |
| Q3 2023 | 15,000 | $22.5K | <0.1% | +15,000 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −3−100.0% | Sold out | Holders |
| Q4 2021 | 3 | $0 | 0.0% | +3 | New | Holders |